PDMR Participation in SAYE Scheme

RNS Number : 9229T
Omega Diagnostics Group PLC
18 October 2017
 

 

Omega Diagnostics Group PLC

("Omega" or the "Company")

 

PDMR participation in SAYE scheme

 

Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that certain PDMRs of the Company have been granted sharesave option awards in the Company's save as you earn scheme ("SAYE Scheme") which gives them the opportunity to participate in the future growth of the Company via share award arrangements.

 

The SAYE Scheme grants participants the option to purchase ordinary shares of 4 pence each in the capital of the Company ("Ordinary Share") at a price of 18.4 pence per Ordinary Share and is exercisable between 1 November 2020 and 1 May 2021.

 

Accordingly, the Company makes the following announcement and notification in accordance with the EU Market Abuse Regulation (No 596/2014):

 

1)

Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA')

a)

Name

John Bannister

2.

Reason for notification

b)

Position / status

PDMR

c)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

b)

Name

Omega Diagnostics Group plc

c)

LEI

2138007U9P4BTZTYIR92

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 Identification code

 

Options over ordinary shares of 4p each

 

GB00B1VCP282

b)

Nature of the transaction

Grant of share options under the Company's SAYE Scheme

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£0.184

23,478

 

 

d)

Aggregated information

Aggregated volume Price

n/a

e)

Date of the transaction

18 October 2017

f)

Place of the transaction

Outside a trading venue

 

1)

Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA')

a)

Name

Derek Brady

2.

Reason for notification

b)

Position / status

PDMR

c)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

b)

Name

Omega Diagnostics Group plc

c)

LEI

2138007U9P4BTZTYIR92

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 Identification code

 

Options over ordinary shares of 4p each

 

GB00B1VCP282

b)

Nature of the transaction

Grant of share options under the Company's SAYE Scheme

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£0.184

14,673

 

 

d)

Aggregated information

Aggregated volume Price

n/a

e)

Date of the transaction

18 October 2017

f)

Place of the transaction

Outside a trading venue

 

1)

Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA')

a)

Name

Patrick Breen

2.

Reason for notification

b)

Position / status

PDMR

c)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

b)

Name

Omega Diagnostics Group plc

c)

LEI

2138007U9P4BTZTYIR92

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 Identification code

 

Options over ordinary shares of 4p each

 

GB00B1VCP282

b)

Nature of the transaction

Grant of share options under the Company's SAYE Scheme

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£0.184

19,565

 

 

d)

Aggregated information

Aggregated volume Price

n/a

e)

Date of the transaction

18 October 2017

f)

Place of the transaction

Outside a trading venue

 

1)

Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA')

a)

Name

Michael Gordon

2.

Reason for notification

b)

Position / status

PDMR

c)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

b)

Name

Omega Diagnostics Group plc

c)

LEI

2138007U9P4BTZTYIR92

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 Identification code

 

Options over ordinary shares of 4p each

 

GB00B1VCP282

b)

Nature of the transaction

Grant of share options under the Company's SAYE Scheme

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£0.184

39,130

 

 

d)

Aggregated information

Aggregated volume Price

n/a

e)

Date of the transaction

18 October 2017

f)

Place of the transaction

Outside a trading venue

 

1)

Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA')

a)

Name

Iain Logan

2.

Reason for notification

b)

Position / status

PDMR

c)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

b)

Name

Omega Diagnostics Group plc

c)

LEI

2138007U9P4BTZTYIR92

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 Identification code

 

Options over ordinary shares of 4p each

 

GB00B1VCP282

b)

Nature of the transaction

Grant of share options under the Company's SAYE Scheme

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£0.184

9,782

 

 

d)

Aggregated information

Aggregated volume Price

n/a

e)

Date of the transaction

18 October 2017

f)

Place of the transaction

Outside a trading venue

 

1)

Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA')

a)

Name

Angela Robertson

2.

Reason for notification

b)

Position / status

PDMR

c)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

b)

Name

Omega Diagnostics Group plc

c)

LEI

2138007U9P4BTZTYIR92

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 Identification code

 

Options over ordinary shares of 4p each

 

GB00B1VCP282

b)

Nature of the transaction

Grant of share options under the Company's SAYE Scheme

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£0.184

19,565

 

 

d)

Aggregated information

Aggregated volume Price

n/a

e)

Date of the transaction

18 October 2017

f)

Place of the transaction

Outside a trading venue

 

1)

Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA')

a)

Name

Edward Valente

2.

Reason for notification

b)

Position / status

PDMR

c)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

b)

Name

Omega Diagnostics Group plc

c)

LEI

2138007U9P4BTZTYIR92

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 Identification code

 

Options over ordinary shares of 4p each

 

GB00B1VCP282

b)

Nature of the transaction

Grant of share options under the Company's SAYE Scheme

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£0.184

78,260

 

 

d)

Aggregated information

Aggregated volume Price

n/a

e)

Date of the transaction

18 October 2017

f)

Place of the transaction

Outside a trading venue

 

1)

Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA')

a)

Name

Jamie Yexley

2.

Reason for notification

b)

Position / status

PDMR

c)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

b)

Name

Omega Diagnostics Group plc

c)

LEI

2138007U9P4BTZTYIR92

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 Identification code

 

Options over ordinary shares of 4p each

 

GB00B1VCP282

b)

Nature of the transaction

Grant of share options under the Company's SAYE Scheme

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£0.184

5,869

 

 

d)

Aggregated information

Aggregated volume Price

n/a

e)

Date of the transaction

18 October 2017

f)

Place of the transaction

Outside a trading venue

 

Contacts:

 

Omega Diagnostics Group PLC                         

Tel: 01259 763 030

Andrew Shepherd, Chief Executive                             

www.omegadiagnostics.com

Kieron Harbinson, Group Finance Director


Jag Grewal, Group Sales and Marketing Director                                                  




finnCap Ltd                                              

Tel: 020 7220 0500

Geoff Nash/James Thompson (Corporate Finance)


Mia Gardner (Corporate Broking)




Walbrook PR Limited

Tel: 020 7933 8780 or omega@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHFFDSWAFWSEES
UK 100

Latest directors dealings